NeOnc Technologies appoints Amir Heshmatpour as CEO; founder Dr. Thomas Chen transitions to CMO/CSO

NEONC TECHNOLOGIES HOLDINGS, INC.

Dr. Thomas Chen resigns as CEO, becomes Chief Medical Officer and Chief Scientific Officer, retains Vice Chairman role.
Amir Heshmatpour appointed CEO effective Oct 31, 2025, in addition to President and Executive Chairman roles.
Heshmatpour to receive $1/year salary and 1.2M restricted stock shares with vesting schedule.
Press release highlights $50M strategic partnership with Quazar Investment and expansion of Scientific Advisory Board.

item 5.02item 7.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.